These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1677212)

  • 1. [Anomaly in the neurotransmitter amino acids in amyotrophic lateral sclerosis: a therapeutic application].
    Blin O; Desnuelle C; Guelton C; Aubrespy G; Ardissonne JP; Crevat A; Pouget J; Serratrice G
    Rev Neurol (Paris); 1991; 147(5):392-4. PubMed ID: 1677212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyotrophic lateral sclerosis: amino acid levels in plasma and cerebrospinal fluid.
    Perry TL; Krieger C; Hansen S; Eisen A
    Ann Neurol; 1990 Jul; 28(1):12-7. PubMed ID: 2375629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Free amino acid contents in the spinal cord of amyotrophic lateral sclerosis].
    Fujita K; Nagata Y; Honda M
    Rinsho Shinkeigaku; 1993 Sep; 33(9):985-7. PubMed ID: 7905368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal glutamate metabolism in amyotrophic lateral sclerosis.
    Plaitakis A; Caroscio JT
    Ann Neurol; 1987 Nov; 22(5):575-9. PubMed ID: 2892463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma amino acids concentration in amyotrophic lateral sclerosis patients.
    Iłzecka J; Stelmasiak Z; Solski J; Wawrzycki S; Szpetnar M
    Amino Acids; 2003 Jul; 25(1):69-73. PubMed ID: 12836061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Amyotrophic lateral sclerosis].
    Moriwaka F
    Hokkaido Igaku Zasshi; 1997 Jan; 72(1):21-5. PubMed ID: 9086359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of riluzole (Rilutek) treatment on plasma amino acid percentages in amyotrophic lateral sclerosis patients.
    Iłzecka J; Stelmasiak Z; Solski J; Wawrzycki S; Szpetnar M
    Neurol Sci; 2003 Nov; 24(4):290-2. PubMed ID: 14658053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma amino acids percentages in amyotrophic lateral sclerosis patients.
    Iłzecka J; Stelmasiak Z; Solski J; Wawrzycki S; Szpetnar M
    Neurol Sci; 2003 Nov; 24(4):293-5. PubMed ID: 14658054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on the glutamatergic neurotransmitter system and the role of excitotoxicity in amyotrophic lateral sclerosis.
    Heath PR; Shaw PJ
    Muscle Nerve; 2002 Oct; 26(4):438-58. PubMed ID: 12362409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma glutamate and glycine levels in patients with amyotrophic lateral sclerosis.
    Andreadou E; Kapaki E; Kokotis P; Paraskevas GP; Katsaros N; Libitaki G; Petropoulou O; Zis V; Sfagos C; Vassilopoulos D
    In Vivo; 2008; 22(1):137-41. PubMed ID: 18396796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma glutamate and glycine levels in patients with amyotrophic lateral sclerosis: the effect of riluzole treatment.
    Andreadou E; Kapaki E; Kokotis P; Paraskevas GP; Katsaros N; Libitaki G; Zis V; Sfagos C; Vassilopoulos D
    Clin Neurol Neurosurg; 2008 Mar; 110(3):222-6. PubMed ID: 18055102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind placebo-controlled trial of L-threonine in amyotrophic lateral sclerosis.
    Blin O; Pouget J; Aubrespy G; Guelton C; Crevat A; Serratrice G
    J Neurol; 1992 Feb; 239(2):79-81. PubMed ID: 1313078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Riluzole and ALS therapy.
    Hugon J
    Wien Med Wochenschr; 1996; 146(9-10):185-7. PubMed ID: 8873431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The neuroexcitotoxic amino acids glutamate and aspartate are altered in the spinal cord and brain in amyotrophic lateral sclerosis.
    Plaitakis A; Constantakakis E; Smith J
    Ann Neurol; 1988 Sep; 24(3):446-9. PubMed ID: 2906529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic trials in amyotrophic lateral sclerosis.
    Olarte MR
    Adv Neurol; 1982; 36():555-7. PubMed ID: 6758531
    [No Abstract]   [Full Text] [Related]  

  • 16. [Free blood amino acids in patients with amyotrophic lateral sclerosis].
    Pivovarova VM
    Klin Med (Mosk); 1972 May; 50(5):78-81. PubMed ID: 5048416
    [No Abstract]   [Full Text] [Related]  

  • 17. Transfer factor is ineffective in amyotrophic lateral sclerosis.
    Olarte MR; Gersten JC; Zabriskie J; Rowland LP
    Ann Neurol; 1979 Apr; 5(4):385-8. PubMed ID: 443772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. L-threonine as a symptomatic treatment for amyotrophic lateral sclerosis (ALS).
    Roufs JB
    Med Hypotheses; 1991 Jan; 34(1):20-3. PubMed ID: 1905383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glutamate dysfunction and selective motor neuron degeneration in amyotrophic lateral sclerosis: a hypothesis.
    Plaitakis A
    Ann Neurol; 1990 Jul; 28(1):3-8. PubMed ID: 1973889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated plasma homocysteine levels in patients with amyotrophic lateral sclerosis.
    Zoccolella S; Simone IL; Lamberti P; Samarelli V; Tortelli R; Serlenga L; Logroscino G
    Neurology; 2008 Jan; 70(3):222-5. PubMed ID: 18195267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.